'AQURO', a new, potentially automatable approach for quatifying mitral regurgitation: technology development and validation through collaboration between cardiovascular science and bioengineering

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14627513

Enrollment

Registered

2010-06-18

Start date

2009-03-23

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Diabetes Research Network

Interventions

Patients are recruited and ultrasound scans are performed for about 40 minutes to be analysed and compared with the standard technique. Study entry: registration only

Eligibility

Inclusion criteria

Inclusion criteria: Stable subjects with mitral regurgitation previously diagnosed on echocardiography

Exclusion criteria

Exclusion criteria: 1. Atrial fibrillation 2. Moderate or severe disease of tricuspid or pulmonary valves 3. Any aortic valve disease graded mild or higher 4. Prosthetic aortic valve and body habitus or coexistent disease that precludes satisfactory imaging quality

Design outcomes

Primary

Measure	Time frame
Effective regurgitant orifice area (EROA), measured during 40 minutes of acquisition	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026